Marex Group’s Humacyte HUMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-13,854
Closed -$23.6K 789
2025
Q1
$23.6K Buy
+13,854
New +$52K ﹤0.01% 660

Other funds holding HUMA

Marex Group's HUMA Position: Q2 2025 in Review

Marex Group sold out of Humacyte (HUMA) in Q2 2025, closing a stake of 13,854 shares — an estimated $23.6K sold.

Marex Group first reported a position in HUMA in Q1 2025 and held it in 1 quarter. The position peaked at $23.6K in Q1 2025. 156 funds tracked by Wall St. Rank hold HUMA as of Q2 2025.

  • Marex Group reported no remaining Humacyte position as of Q2 2025 after selling out during the quarter.
  • Marex Group sold 13,854 Humacyte shares in Q2 2025, an estimated $23.6K.
  • Marex Group first reported a position in Humacyte in Q1 2025 and held it in 1 quarter.
  • Marex Group's Humacyte position peaked at $23.6K in Q1 2025.
  • 156 funds tracked by Wall St. Rank held Humacyte as of Q2 2025.

Based on Marex Group's 13F filing for Q2 2025, filed 19 Aug 2025.